BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)
[BIOSTAR PHARMACEUTICALS, RECEIVES NEWVERTISING APPROVAL FROM SHAANXI SFDA FOR MARKETING XIN AOXINGPSULE XIANYANG, China, April 27, 2010 (Xinhua-PRNewswire-FirstCall) On April 22, 2010 the Shaanxi SFDA published on its website a notification stating that the marketing language used innnection with several pharmaceutical products sold in the province are not within approved parameters.Biostar Pharmaceuticals flagship Hepatitis B]
